Teva, the world's largest generic drug company, refused Tuesday to reconsider a decision to close its Jerusalem plant despite pressure from Prime Minister Benjamin Netanyahu, the government and group said.
Teva will make 1,750 employees redundant in Israel as part of plans to slash 14,000 jobs worldwide over two years, according to the Histadrut trade union.
The cuts would amount to moreRead more
Israeli pharmaceutical giant Teva announced Thursday it plans 14,000 job cuts over two years as it unveiled a wide-reaching restructuring plan after facing low prices for generic drugs.
Teva also said it was suspending dividends on ordinary shares and its annual bonus for 2017 will not be paid “due to the fact that the company’s financial results are significantly belowRead more
Israeli pharmaceutical giant Teva announced Thursday it plans 14,000 job cuts over two years as it unveiled a wide-reaching restructuring plan after facing low prices for generic drugs.
Teva also said it was suspending dividends on ordinary shares and its annual bonus for 2017 will not be paid "due to the fact that the company's financial results are significantly belowRead more
Israel's powerful Histadrut trade union has called a nationwide strike for Sunday following reports that troubled drug giant Teva Pharmaceutical Industries will axe thousands of jobs.
The head of the Histadrut labour union, Avi Nissenkorn, said the strike against the "shameful" cuts would last for several hours.
It would affect the entire public sector, as well as banks, the stockRead more
Pharmaceutical giant Teva is preparing to sack thousands of employees in Israel and the United States, including one quarter of its Israeli workforce, a business newspaper said Thursday.
Israel-based Teva, the world's biggest manufacturer of generic drugs, will sack 25 percent of its 6,860 employees in Israel and more than 10 percent of its 10,000-strong workforce in the US, CalcalistRead more
Pharmaceutical giant Teva said on Wednesday it is under investigation by Israeli police for suspected bribery of foreign officials just two months after it paid $519 million to settle US charges.
The news came a day after the world's biggest manufacturer of generic drugs said in a surprise announcement that its CEO was quitting after just three years at theRead more